Literature DB >> 21127892

Development of bullous retinal detachment during systemic corticosteroid treatment.

Xinxiao Gao, Xiaoxin Li.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 21127892     DOI: 10.1007/s00417-010-1582-8

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  4 in total

1.  Bullous retinal detachment. An unusual manifestation of idiopathic central serous choroidopathy.

Authors:  J D Gass
Journal:  Am J Ophthalmol       Date:  1973-05       Impact factor: 5.258

Review 2.  Bullous variant of idiopathic central serous chorioretinopathy.

Authors:  D K Sahu; P Namperumalsamy; G F Hilton; N F de Sousa
Journal:  Br J Ophthalmol       Date:  2000-05       Impact factor: 4.638

3.  Exacerbation of central serous chorioretinopathy following intravitreal triamcinolone injection.

Authors:  M Selim Kocabora; Sahan Durmaz; Nilay Kandemir
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-03       Impact factor: 3.117

4.  Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy.

Authors:  J D Gass; H Little
Journal:  Ophthalmology       Date:  1995-05       Impact factor: 12.079

  4 in total
  3 in total

1.  Atypical Central Serous Chorioretinopathy.

Authors:  Zafer Cebeci; Merih Oray; Şerife Bayraktar; İlknur Tuğal-Tutkun; Nur Kır
Journal:  Turk J Ophthalmol       Date:  2017-08-15

2.  Photodynamic therapy for bullous retinal detachment: a single-center experience of case series with a 6-month follow-up study.

Authors:  Tingting Gao; Jinfeng Qu; Jing Xiao; Jie Hu; Mingwei Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-04       Impact factor: 3.117

3.  Comparison of rapid antibody test and thorax computed tomography results in patients who underwent RT-PCR with the pre-diagnosis of COVID-19.

Authors:  Ilker Kızıloglu; Aslı Sener; Neslihan Siliv
Journal:  Int J Clin Pract       Date:  2021-07-06       Impact factor: 3.149

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.